$AXGN

Axogen, Inc. (AXGN): Submission of Matters to a Vote of Security Holders

Axogen, Inc. (AXGN) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. axgn-20260623 0000805928 false 0000805928 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Jun 23, 2026, 8:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$AXGN
Neutral
high confidence
Mentioned
$AXGN
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AXGNNeutralLow
01

Why it matters

The disclosure confirms board election results, ratification of Deloitte & Touche LLP as independent auditors for FY ending Dec. 31, 2026, and approval of the advisory executive compensation proposal.

02

Market read

This is a governance/administrative update with no new fundamentals; it is unlikely to drive trading beyond routine compliance visibility.

03

What to watch

Traders may instead focus on any separate contemporaneous filings (earnings, guidance, litigation, financing) that are not included in this Item 5.07 report.

Relevance 6/10Novelty 2/10Timing: after-hours/filing on June 23, 2026 (8-K Item 5.07)

Background

The company submitted Form 8-K under Item 5.07 to report matters voted on by shareholders at its 2026 annual meeting.

Company-level read

Ticker impact

$AXGNNeutralHigh confidence
Context

Axogen filed an 8-K reporting shareholder voting results: directors elected, Deloitte ratified, and executive compensation approved at the June 23, 2026 annual meeting.

Expected impact

Limited near-term impact; any reaction is likely muted unless investors were focused on governance outcomes.

Evidence & confidence

The filing is a standard Item 5.07 tabulation of votes (board election, auditor ratification, advisory comp vote) without new operating or financial disclosures.

Market effects

No sector read-across; governance vote results are company-specific and routine.

None.

None.

Counterpoint

If governance outcomes were contested, the vote tabulations could briefly affect sentiment, but the filing provides no indication of controversy or changes in control.

Key entities

  • Axogen, Inc.

    Nasdaq-listed medical technology company; subject of the 8-K reporting annual meeting vote results.

  • Deloitte & Touche LLP

    Selected and ratified as the company’s independent public accounting firm for FY ending Dec. 31, 2026.

Related articles

$AXGNMedAI 8/10

Axogen (AXGN) Q2 2026 Earnings Call Transcript

Axogen (AXGN) reported Q2 2026 revenue of $69.7 million, up 23.1% year over year, driven by growth in breast, extremities, and OMF. Breast revenue grew more than 50% and contributed about two-thirds of growth. Gross margin was 72.7%. Adjusted net income was $7.3 million ($0.12/share). Full-year revenue guidance raised to at least $279 million (24% growth) and gross margin to at least 73%.

$AXGNMed

Axogen, Inc. (AXGN): Results of Operations and Financial Condition

Axogen, Inc. (AXGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991axgnearningsreleaseda.htm EX-99.1 Q2 2026 EARNINGS PRESS RELEASE Document Exhibit 99.1 Axogen, Inc. Reports Second Quarter 2026 Financial Results Raises Full Year Revenue Guidance to at Least 24% Growth or $279 million ALACHUA and TAMPA, FL – July 29, 2026 – Axogen

$SNRGMed

Trump administration to invest $3 billion into minerals projects to boost defense supply

The Trump administration said it will invest $3 billion in US critical-minerals projects to support defense supply. The Pentagon’s Office of Strategic Capital plans conditional loans of $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics. The Export-Import Bank will lend $58M to several firms, while DOE and Pentagon grants target mining education.

$MSTRMed

What Is Strategy (MSTR) Planning With Its $15 Billion Bitcoin Backed Preferred Stock?

Strategy Inc (MSTR) says it has launched a Bitcoin-backed preferred stock structure, backed by its Bitcoin holdings, and raised about $15 billion, according to the company. Management describes it as a “capital flywheel” to fund future digital-asset initiatives. The article notes Strategy’s recent large net losses and highlights upcoming dividend and cash-flow tests.

SK Hynix Adds $38.1 Billion in New Memory

SK Hynix said it will invest 54 trillion won (about $38.1 billion) to build two new memory-chip fabs. It plans 35.2 trillion won for the Y2 fab in Yongin and 19.1 trillion won for M17 in Cheongju, aimed at demand expected in 2029 and beyond, driven by AI memory growth.

$000660.KSMedAI 8/10

SK hynix approves $38B+ investment in two new memory fabs

SK hynix approved construction of two new memory fabs costing 54 trillion won (about $38.3B). The Yongin Y2 DRAM fab will cost $25B, with groundbreak in July 2027 and first cleanroom in June 2029, focused on DRAM and HBM. A separate NAND fab is expected to open its first cleanroom in Dec 2028. Samsung is also developing stackable memory tech.